baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out AMGN/ DE000UP0CZP7 /

17/01/2025 10:30:07	Chg.-0.010	Bid-	Ask-	Underlying	Strike price	Expiration date	Option type
2.040EUR	-0.49%	- Bid Size: -	- Ask Size: -	Amgen Inc	479.201 USD	31/12/2078	Put

TeleTrader 02/12/2024 US closes mostly higher on business sector news

TeleTrader 26/11/2024 Dow extends losses, drops by 300 points

TeleTrader 26/11/2024 Amgen plunges 11%, hits lowest level in a year

TeleTrader 26/11/2024 US opens mostly higher ahead of Fed's minutes

TeleTrader 12/11/2024 Wall Street closes lower as markets brace for CPI data

TeleTrader 30/10/2024 Amgen reports revenue of $8.5B in Q3, up 23%

TeleTrader 25/09/2024 Dow falls 290 pts at close as S&P 500 slips from record highs

GlobeNewswire 29/08/2024 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 28/08/2024 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...

GlobeNewswire 26/08/2024 Molecular Partners Reports H1 2024 Corporate Highlights and Financials

GlobeNewswire 26/08/2024 Eliem Therapeutics Announces Additions to its Leadership Team

GlobeNewswire 15/08/2024 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 12/08/2024 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08/08/2024 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/08/2024 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

TeleTrader 07/08/2024 US closes lower with earnings in focus

TeleTrader 07/08/2024 US turns red, Dow loses more than 200 pts

GlobeNewswire 07/08/2024 89bio Appoints Francis Sarena as Chief Operating Officer

TeleTrader 06/08/2024 Amgen books revenue of $8.4B in Q2, up 20%

TeleTrader 06/08/2024 US extends premarket gains, Dow surges 250 pts

GlobeNewswire 05/08/2024 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors

TeleTrader 01/08/2024 Dow jumps 250 pts as Meta surges more than 10%

GlobeNewswire 01/08/2024 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 22/07/2024 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...

GlobeNewswire 09/07/2024 ImCheck Appoints Stephan Braun as Chief Medical Officer

UBS Knock-Out AMGN/ DE000UP0CZP7 /

If you wish to receive reply to your feedback, please provide your email address.